Old Web
HBV reactivation, flare and fulminant hepatitis in patients receiving non-rituximab chemotherapy.
2015
e20729 Background: Hepatitis B reactivation and fulminant hepatitis have been observed in patients (pts) who receive certain anti-neoplastic agents, specially rituximab. Such risks caused by other ...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI